Objective. To investigate whether the balance of blood follicular helper T (Tfh) cells and T follicular regulatory (Tfr) cells can provide information about ectopic lymphoid neogenesis and disease activity in primary Sj€ ogren's syndrome (SS).
Methods. We prospectively recruited 56 patients clinically suspected of having SS. Sixteen of these patients subsequently fulfilled the American-European Consensus Group criteria for SS and were compared to 16 patients with non-SS sicca syndrome. Paired blood and minor salivary gland (MSG) biopsy samples were analyzed to study Tfr cells and subsets of Tfh cells in both compartments.
Results. Patients with primary SS had normal Tfh cell counts in peripheral blood; however, activated programmed death 1-positive (PD-1+) inducible costimulator-positive (ICOS+) Tfh cells in peripheral blood were strongly associated with disease activity assessed by the European League Against Rheumatism Sj€ ogren's Syndrome Disease Activity Index (r = 0.8547, P = 0.0008). Conversely, the blood Tfr cell:Tfh cell ratio indicated ectopic lymphoid structure formation in MSGs, being strongly associated with B cell, CD4+ T cell, and PD-1+ICOS+ T cell infiltration in MSGs, and was especially increased in patients with focal sialadenitis. Further analysis showed that the blood Tfr cell:Tfh cell ratio allowed discrimination between SS patients and healthy donors with excellent accuracy and was a strong predictor of SS diagnosis (odds ratio [OR] 12.96, P = 0.028) and the presence of focal sialadenitis (OR 10, P = 0.022) in patients investigated for sicca symptoms, thus highlighting the potential clinical value of this marker.
Conclusion. The blood Tfr cell:Tfh cell ratio and PD-1+ICOS+ Tfh cells constitute potential novel biomarkers for different features of primary SS. While the blood Tfr cell:Tfh cell ratio is associated with ectopic lymphoid neogenesis, activated Tfh cells indicate disease activity.
Sj€ ogren's syndrome (SS) is characterized by lymphocytic infiltration of salivary and lacrimal glands, leading to xerostomia and keratoconjunctivitis sicca (1) (2) (3) . However, as in other autoimmune diseases, disease heterogeneity remains a challenge to the development of better therapeutic approaches. Disease manifestations are mediated by complex mechanisms involving innate type I interferon signature and autoantibodies produced during dysregulated adaptive immune responses (2) . Ectopic lymphoid structures (4) (5) (6) found in salivary and lacrimal glands are major sites of autoantibody production (2, 7, 8) . These B lymphocyte-T lymphocyte aggregates define soSupported by Fundac ßão para a Ciência e Tecnologia (grants HMSP-ICT/0034/2013, FAPESP/19906/2014, and PTDC/IMI-IMU/ 7038/2018), and by FEDER, through POR Lisboa 2020 -Programa Operacional Regional de Lisboa, PORTUGAL 2020, and Fundac ßão para a Ciência e a Tecnologia (LISBOA-01-0145-FEDER-007391). 1 called focal sialadenitis, the histologic hallmark of SS, and have prognostic significance (9, 10) . Nevertheless, many patients fulfill classification criteria for SS with almost normal salivary gland histology, consistent with a highly heterogeneous disease. It is not known whether clinical heterogeneity could be explained by different immunopathogenic mechanisms. However, it is reasonable to hypothesize that patients with focal sialadenitis, especially those with ectopic germinal center (GC) formation, constitute a subgroup of patients more suitable for therapies targeting B lymphocyte-T lymphocyte interactions.
Dysregulated GC reactions in secondary and tertiary lymphoid organs underlie the generation of self-reactive autoantibodies and many aspects of autoimmune diseases (4, 5) . GC reactions are orchestrated mainly by follicular helper T (Tfh) cells and T follicular regulatory (Tfr) cells. Tfh cells provide cognate help to B cells, thus promoting their clonal selection and affinity maturation (11) . Conversely, Tfr cells regulate and limit the GC reaction assuring antigen-specific antibodies are produced (12) (13) (14) (15) (16) . While the precise mechanisms of Tfr cell functions are not fully understood, unbalanced Tfh and Tfr cell responses may prompt antibody-mediated autoimmune diseases.
We have previously described an increased Tfr cell: Tfh cell ratio in peripheral blood of SS patients (17) .
Furthermore, we demonstrated that blood Tfr cells are immature and not yet fully specialized in suppressing humoral responses. However, the relationship between blood and tissue Tfr cells remains elusive in patients with immune-mediated diseases. In the present study, we investigated the potential role of blood Tfr and Tfh cells as biomarkers of ectopic lymphoid activity in the target organ of SS.
PATIENTS AND METHODS
Human samples. We recruited 56 patients referred to the Rheumatology and Metabolic Bone Diseases Department of Hospital de Santa Maria, Lisbon, Portugal, for minor salivary gland (MSG) biopsy due to clinically suspected SS. Fresh blood samples were collected on the day of MSG biopsy. MSG tissue was divided for routine diagnostic purposes and for flow cytometry and microscopy. We excluded patients treated with biologic drugs, disease-modifying antirheumatic drugs other than hydroxychloroquine, or >7.5 mg per day of prednisolone or equivalent, patients diagnosed as having an infectious disease or who had received any vaccine in the previous month, and patients with exclusion criteria for SS according to the American-European Consensus Group (18) (19) . Routine serum autoantibody levels, C-reactive protein levels (mg/dl), erythrocyte sedimentation rates (mm/hour), and serum electrophoresis gamma fraction , anti-SSA/Ro 52, anti-SSA/Ro 60, anti-SSB), rheumatoid factor (RF; IU/ml), serum electrophoresis gamma fraction levels (gm/dl), C-reactive protein (CRP) level (mg/dl), erythrocyte sedimentation rate (ESR; mm/hour), and disease activity measured by the European League Against Rheumatism Sj€ ogren's Syndrome Disease Activity Index (ESSDAI) in SS patients (n = 16). * = P < 0.05; ** = P < 0.01; *** = P < 0.001 by Pearson correlation test. G, Correlation of peripheral blood Tfr cell:Tfh cell ratio with serum anti-SSA/Ro 60 titer (left) and correlation of blood PD-1+ICOS+ Tfh cells with serum anti-SSA/Ro 52 titer (center) and ESSDAI score (right) (n = 16). Shown are linear regression lines with interpolated 95% confidence interval curves (broken lines). In A-D, symbols represent individual subjects; bars show the mean AE SEM. Significance was determined by Student's unpaired t-test with Welch's correction for variance in A-C; by Student's unpaired t-test in D and E. CU = chemiluminescence units. levels (gm/dl) closest to the time of blood collection were used. Fresh blood was collected from age-and sex-matched healthy controls. Tonsils were obtained from children who had undergone tonsillectomy due to tonsil hypertrophy (n = 6). Children with any clinical condition, being treated with any drugs, or with chronic tonsillitis were excluded. Blood samples were collected in EDTA-coated tubes.
This study was approved by the Lisbon Academic Medical Center Ethics Committee (reference no. 505/14). Informed consent was obtained from all study participants.
Cell isolation and flow cytometry. Peripheral blood mononuclear cells were isolated by Ficoll gradient medium (Histopaque-1077; Sigma-Aldrich) using SepMate tubes (StemCell Technologies). Lymphocytes from tonsils were also isolated by Ficoll gradient medium after mechanical disruption. To study human MSG biopsy samples, we first optimized the experimental protocol to ensure that enzymatic digestion of tissue had negligible impact on cellular markers (see Supplementary Figure 2A , http://onlinelibrary.wiley.com/doi/10.1002/art. 40424/abstract). We then used the optimized protocol to obtain a cell suspension from MSGs. Briefly, MSG fragments were incubated at 37°C with 0.1 mg/ml Liberase and 0.1 mg/ml DNase I in RPMI medium followed by mechanical digestion to obtain a cell suspension. To normalize cell counts, MSGs were weighed before digestion (see Supplementary Figure 2B ). Antibodies used for flow cytometry are described in Supplementary Immunohistochemistry microscopy. MSGs were fixed in 10% buffered formaldehyde, embedded in paraffin wax, and sectioned into 3-lm sequential sections. Sections were stained after deparaffinization, pretreatment with Ultra CC1 (Ventana Medical Systems), antigen retrieval, and endogenous peroxidase blocking using a Benchmark machine (Ventana Medical Systems). Sections were immunohistochemically stained with anti-human CD20 (L26; Dako), anti-human CD21 (EP3093; Roche), anti-human Bcl-6 (LN22; Leica), Alexa Fluor 488-conjugated anti-human CXCR5 (J252D4; BioLegend), and anti-human FoxP3 (236A/E7; eBioscience). The sections were then treated with peroxidaselabeled secondary antibody and visualized with a solution of the chromogen diaminobenzidine and/or Universal AP Red (Ventana Medical Systems). Hematoxylin was used as counterstaining. Images were acquired with a NanoZoomer-SQ single slide scanner (Hamamatsu) using a 209 objective with a numerical aperture of 0.75. Images were further analyzed using NDP.view software (Hamamatsu). Numbers of CXCR5 and FoxP3 double-positive 
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cells were counted manually. Routine hematoxylin and eosin staining was used to define histologic diagnosis in MSGs, as follows: normal = section with no pathologic findings; lymphocytic infiltration = sections with nonspecific lymphocytic infiltration; focal sialadenitis = sections with ≥1 dense aggregate of ≥50 lymphocytes per 4 mm 2 of tissue in perivascular or periductal locations (20) (see Supplementary Figure 2G , http://onlinelibrary.wiley.com/doi/ 10.1002/art.40424/abstract). Statistical analysis. Student's unpaired t-test, one-way analysis of variance (ANOVA) with Tukey's honest significant difference post hoc test for pairwise multiple comparisons, and two-way ANOVA with Bonferroni post hoc test for multiple comparisons were used as described. Normality of data was assessed using the Shapiro-Wilk normality test. Equality of variance across groups was assessed with Levene's test and the Brown-Forsythe test and, when variance across groups differed, Welch's correction of t-test or the Mann-Whitney U test was used. Pearson's correlation and linear regression were also performed for some data. For categorical variables, Fisher's exact test was used. Logistic regression and receiver operating characteristic (ROC) curve analysis were performed to study the association of Tfr cell:Tfh cell ratio with SS and focal sialadenitis, and the cutoff with the best discriminative value was determined. Results are presented as the mean AE SD or as the mean AE SEM as described. P values less than 0.05 were considered significant. GraphPad Prism software, version 5 and Stata software, version 12.1 (StataCorp) were used for statistical and graphic analysis. Correlation heatmaps were computed in R studio software, version 3.1.2 (www.r-project.org).
RESULTS
Activated programmed death 1-positive (PD-1+) inducible costimulator-positive (ICOS+) Tfh cells in peripheral blood correlate with SS disease activity. We previously reported that SS patients had normal CXCR5+CD45RO+ Tfh cells, increased CXCR5+FoxP3+ Tfr cells, and an increased Tfr cell:Tfh cell ratio in peripheral blood (17) . To refine our analysis, we now studied only patients with primary SS, and we further characterized blood Tfh cell subsets in those patients. Consistently, patients with primary SS showed an increased frequency of blood Tfr cells and an increased blood Tfr cell:Tfh cell ratio compared to healthy donors ( Figures 1A and B) . Interestingly, while patients with primary SS had decreased absolute numbers of all CD4+ T cell subsets, consistent with their CD4+ T cell lymphopenic state, their absolute numbers of Tfr cells were not different from those in healthy donors (see Supplementary Figures 3A-D, http://onlinelibrary.wiley.com/doi/10.1002/art.40424/ abstract), which suggests that the Tfr cell subset is indeed overrepresented in these patients.
We did not find a significant increase in activated PD-1+ICOS+ Tfh cells or PD-1+CXCR3-GC-like Tfh cells in SS patients (21) (22) (23) (24) (25) (Figures 1C and D) . Contrary to previous reports (26) , SS patients had a normal distribution of Tfh1-, Tfh2-, and Tfh17-like cells ( Figure 1E ; also see Supplementary Figure 3E ). To investigate whether follicular T cell subsets correlated with autoantibodies, markers of inflammation, and disease activity, we computed correlation heatmaps. We found that the blood Tfr cell:Tfh cell ratio and PD-1+ICOS+ Tfh cells correlated significantly with the presence of anti-SSA/Ro 60 
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(r = 0.5796, P = 0.0298) and anti-SSA/Ro 52 (r = 0.5583, P = 0.0474), respectively ( Figures 1F and G) . While most correlations were barely significant, we found a very strong association between the frequency of activated PD-1+ ICOS+ Tfh cells and disease activity as measured by the ESSDAI (r = 0.8547, P = 0.0008) (Figures 1F and G) . Interestingly, the blood Tfr cell:Tfh cell ratio and PD-1+ ICOS+ Tfh cells consistently correlated in different directions with the variables analyzed, although this did not always reach statistical significance ( Figure 1F ).
Blood Tfr cell:Tfh cell ratio identifies pathologic lymphocytic infiltration in the target organ of SS. As the Tfr cell:Tfh cell ratio may predict the outcome of GC reactions (12,27), we hypothesized that in patients with autoimmune diseases with abnormal GC reactions leading to autoantibody production, the Tfr cell:Tfh cell ratio might be altered. As GC reactions take place in lymphoid tissues and ectopic (or tertiary) lymphoid structures, we studied MSG tissue biopsy samples from patients with primary SS and controls with non-SS sicca syndrome (see Supplementary Figure 1 and Supplementary Table 1 , http://onlinelibrary.wiley.com/doi/10. 1002/art.40424/abstract).
SS patients had an increased frequency and absolute number (per mg of tissue) of nonepithelial CD45+ cells ( Figure 2A ) and CD19+ B cells ( Figure 2B ). Loss of CXCR5 following enzymatic digestion due to a tissueintrinsic factor excluded direct analysis of tissue Tfh and Tfr cells (see Supplementary Figures 2A, C , and D, http://onlinelibrary.wiley.com/doi/10.1002/art.40424/abstract). Nevertheless, as~90% of PD-1+ICOS+ T cells in lymphoid tissues were CXCR5+ Tfh cells, we assessed salivary gland infiltration by PD-1+ICOS+ T cells ( Figure 2C ; also see Supplementary Figure 2E ). We found a strikingly increased frequency and absolute number of infiltrating PD-1+ICOS+ Tcells in SS patients ( Figure 2C ). Although it is likely that this cell population comprises tissue Tfh cells, we cannot exclude the existence of CXCR5-PD-1+ICOS+ T cells, described as a specific type of Th cell within ectopic lymphoid structures in rheumatoid arthritis patients (28) . In both cases, our findings suggest that MSG tissue from patients with primary SS host active T cell-dependent humoral immune responses. To validate our results, we compared MSG analysis by flow cytometry to routine histologic diagnosis of the same biopsy samples (see Supplementary Figure 2F ). Infiltration by CD19+ B cells was found in all SS patients irrespective of salivary gland morphology. However, only patients with ectopic lymphoid structures/focal sialadenitis had a significantly higher infiltration by B cells as compared to patients with non-SS sicca syndrome (see Supplementary Figure 2G ).
When we compared blood Tfh and Tfr cell populations to lymphocytic MSG infiltration in patients with SS, we found a strong correlation between the blood Tfr cell: Tfh cell ratio and the presence of ectopic lymphoid structures in exocrine glands. Indeed, the blood Tfr cell:Tfh cell ratio was positively correlated with tissue infiltration by CD4+ T cells (r = 0.8475, P = 0.0039), PD-1+ICOS+ T cells (r = 0.8400, P = 0.0180), and CD19+ B cells (r = 0.6748, P = 0.0462) (Figures 2D and E) . Moreover, blood Tfr cells were also positively correlated with tissue CD19+ B cells (r = 0.6690, P = 0.0488), and a positive trend was seen with other local populations ( Figure 2D ). Interestingly, although not significantly, blood Tfh cells and Tfh cell subsets tended to correlate negatively with tissue infiltration by most inflammatory cells analyzed, showing a trend opposite to that of blood Tfr cells and the Tfr cell: Tfh cell ratio ( Figure 2D ). Taken together, these data suggest that blood Tfr cells and the Tfr cell:Tfh cell ratio indicate pathologic lymphocytic infiltration in the target organ of SS. On the other hand, activated PD-1+ICOS+ Tfh cells in peripheral blood correlated with disease severity assessed by the ESSDAI (Figure 1F ), but did not show a positive correlation with MSG lymphocytic infiltration ( Figure 2D) . Indeed, the presence of focal sialadenitis did not correlate with the ESSDAI (see Supplementary Figure 4A , http://onlinelibrary.wiley.com/doi/ 10.1002/art.40424/abstract), as previously shown (29, 30) .
To test whether increased blood Tfr cells and the increased Tfr cell:Tfh cell ratio observed in patients are due to selective exclusion of Tfr cells from ectopic lymphoid structures, we directly accessed infiltration of CXCR5+FoxP3+ Tfr cells in MSG biopsy samples using microscopy. MSG biopsy samples from patients with focal sialadenitis were further studied to identify ectopic lymphoid structures based on the presence of organized CD20+ B cell aggregates and infiltration by CD21+ follicular dendritic cells (FDCs) (31) (see Supplementary Figures 4B and C, http://onlinelibrary.wiley.com/doi/10.1002/ art.40424/abstract). As only 1 patient had focal sialadenitis without infiltration by CD21+ FDCs, we assumed that focal sialadenitis was a good indicator of ectopic lymphoid structures in our cohort (see Supplementary Figure 4B) . Additionally, 2 patients with focal sialadenitis were found to have Bcl-6+ ectopic GC formation (see Supplementary Figures 4B and C) . We found a substantial number of CXCR5+FoxP3+ Tfr cells within ectopic lymphoid structures in MSGs from SS patients following a bimodal distribution, with one group of patients having a tissue Tfr cell density 10-fold greater than that in the other group ( Figure 2F ). We therefore assessed whether the tissue density of Tfr cells correlated with diseaserelated parameters (see Supplementary Table 3, http://   780 FONSECA ET AL onlinelibrary.wiley.com/doi/10.1002/art.40424/abstract). We found a strong correlation of tissue Tfr cells with PD-1+ ICOS+ T cell infiltration (see Supplementary Table 3) . Overall, our data show that Tfr cells are not excluded from ectopic lymphoid structures in inflamed exocrine glands of SS patients. Blood Tfr cell:Tfh cell ratio as a marker of SS and focal sialadenitis. The presence of focal sialadenitis on MSG biopsy is a major diagnostic and prognostic marker of primary SS (9, 20, 32) and one of the diagnostic criteria established by the American-European Consensus Group in 2002 (18) . As the blood Tfr cell:Tfh cell ratio was increased in SS patients compared to healthy donors and associated with MSG lymphocytic infiltration, we wondered whether this ratio could aid in the identification of patients with SS and ectopic lymphoid activity (typical focal sialadenitis).
The blood Tfr cell:Tfh cell ratio was significantly higher in SS patients compared to healthy donors and patients with non-SS sicca syndrome ( Figure 3A) . This ratio was a significant predictor of SS when compared to healthy donors, with a 4.97-fold increase in the odds of having SS for every decimal increase in the Tfr cell:Tfh cell ratio (area under the curve [AUC] 0.820, P = 0.008) (Figures 3B and C) . Through ROC curve analysis, we found that a cutoff of ≥0.2780 correctly classified 84.4% of patients with 100% specificity and 68.8% sensitivity. Compared to non-SS sicca syndrome, the Tfr cell:Tfh cell ratio Figure 3 . Blood Tfr cell:Tfh cell ratio as a marker of primary SS and focal sialadenitis (FSA). A, Blood Tfr cell:Tfh cell ratio in SS patients (n = 16), patients with non-SS sicca syndrome (non-SSS; n = 11), and healthy donors (n =16). B, Receiver operating characteristic (ROC) curves for prediction of SS diagnosis (versus healthy donors and versus patients with non-SS sicca syndrome) based on the Tfr cell:Tfh cell ratio. AUC = area under the curve. C, Odds ratio (OR), P value, and AUC of logistic regression models predicting SS diagnosis (versus healthy donors and versus patients with non-SS sicca syndrome) and focal sialadenitis (versus normal histology or nonspecific lymphocytic infiltration [LI]) based on the Tfr cell:Tfh cell ratio as a continuous variable or as specific cutoffs. The Tfr cell:Tfh cell ratio is transformed by 1 decimal place (9 10 1 ) for better interpretation of the OR. Shown are percentages of sensitivity, specificity, and correct classification of patients based on given cutoffs. NA = not applicable. D, Blood Tfr cell:Tfh cell ratio in patients with sicca symptoms (with focal sialadenitis [n = 7] or normal histology/nonspecific lymphocytic infiltration [n = 20]) undergoing minor salivary gland biopsy. E, ROC curve for prediction of focal sialadenitis diagnosis (versus normal histology/nonspecific lymphocytic infiltration) based on the Tfr cell:Tfh cell ratio. In A and D, data are presented as box plots, where the boxes represent the 25th to 75th percentiles, the lines within the boxes represent the median, and the lines outside the boxes represent the 10th and 90th percentiles. In A, significance was determined by Student's unpaired t-test with Welch's correction for variance except when variance was not significantly different between groups (patients with non-SS sicca syndrome versus healthy donors); one-way analysis of variance was used to compare all 3 groups. In D, significance was determined by Mann-Whitney U test due to skewed distribution of values and nondifferent variance according to the Brown-Forsythe test. See Figure 1 for other definitions.
tended to associate with SS diagnosis (odds ratio [OR] 1.93, P = 0.099, AUC 0.716), with the best cutoff to diagnose SS being a blood Tfr cell:Tfh cell ratio ≥0.3009 (Figures 3B and C) . Thus, patients with sicca symptoms and a Tfr cell:Tfh cell ratio ≥0.3009 had a 12.96-fold increase in the odds of having SS, with very high specificity (90.9%) but moderate sensitivity (56.3%) ( Figure 3C) .
Importantly, the blood Tfr cell:Tfh cell ratio was significantly increased in patients with focal sialadenitis compared to those with normal histology or mild nonspecific inflammation, irrespective of diagnosis ( Figure 3D ). Moreover, it significantly predicted the result of MSG biopsy (focal sialadenitis versus no focal sialadenitis), with a 2.03-fold increase in the odds of having focal sialadenitis for every decimal increase in the Tfr cell:Tfh cell ratio (AUC 0.793, P = 0.047) ( Figures 3C and E) . Values of the blood Tfr cell:Tfh cell ratio ≥0.3020 were significantly associated with focal sialadenitis (OR 10, P = 0.022, AUC 0.757), with good sensitivity (71.4%) and very good specificity (80%) ( Figure 3C ).
DISCUSSION
Our results show that activated Tfh cells in peripheral blood and the Tfr cell:Tfh cell ratio are associated with disease activity and ectopic lymphoid structures in MSGs, respectively, in primary SS. Indeed, there is a striking association between a high Tfr cell:Tfh cell ratio and ectopic lymphoid activity in salivary glands, the target organ of this disease. In addition, circulating PD-1+ ICOS+ Tfh cells seem to indicate disease activity and not formation of ectopic lymphoid structures.
The relationship between circulating PD-1+ ICOS+ Tfh cells and the ESSDAI was an exciting finding. While many studies have established that circulating activated Tfh cells are correlated with disease severity in autoimmunity (33) (34) (35) , circulating Tfh cells had not previously been correlated with the ESSDAI. Notably, other Tfh cell subsets, namely, Tfh17-like cells identified in other immune-mediated diseases (35), were not altered in our cohort of patients with primary SS. These results suggest that PD-1+ICOS+ Tfh cells may be directly involved in the pathogenesis of SS, particularly in those patients with greater inflammatory activity and high ESS-DAI scores. A recent study showed that the ESSDAI is an independent predictor of lymphoma development in primary SS (36) , thus raising the possibility that increased circulating PD-1+ICOS+ Tfh cells are somehow related to the same mechanism that will culminate in hematologic malignancy.
The predictive value of Tfr cells, and especially the Tfr cell:Tfh cell ratio, regarding the diagnosis of primary SS and pathologic lymphocytic infiltration in salivary glands may appear counterintuitive, given the regulatory role attributed to Tfr cells (12, 13) . However, we have recently shown that human blood Tfr cells remain immature and are generated prior to T cell-B cell interactions required for acquisition of follicle access and full regulatory function (17) . The increased proportion of Tfr cells in peripheral blood of SS patients did not seem to be due to anatomic exclusion of Tfr cells from inflamed exocrine glands, as substantial numbers of Tfr cells were found within ectopic lymphoid structures containing B cells in the majority of patients. It is generally assumed that ectopic lymphoid structures are populated by lymphocytes formed outside these structures, in secondary lymphoid organs (4, 6) . Therefore, it is likely that Tfr cells result from enhanced differentiation in secondary lymphoid organs due to ongoing humoral responses. Our data suggest that accumulation of Tfr cells is not sufficient to restore tolerance in exocrine glands (where the first step of SS pathogenesis occurs), although we did not directly address the presence of Tfr cells in ectopic lymphoid structures with and without GCs (3). A recent report claimed that salivary gland epithelial cells induce Tfh cell differentiation from naive CD4+ Tcells (37) . While it is not known whether Tfr cell differentiation can also occur in situ, this possibility could provide an alternative explanation for the increased proportion of blood Tfr cells in SS.
The blood Tfr cell:Tfh cell ratio does seem to be a specific marker of SS and of ectopic lymphoid structure formation within salivary glands. Indeed, we found that the Tfr cell:Tfh cell ratio could discriminate between SS patients and healthy donors with excellent accuracy, with a specific cutoff above which the diagnosis of SS was almost certain. Even more important, this ratio was also helpful in predicting a diagnosis of primary SS and the presence of focal sialadenitis in MSG biopsy specimens from a group of patients investigated for sicca symptoms, thus highlighting the potential clinical value of this marker. The proposed cutoffs of blood Tfr cell:Tfh cell ratio above or equal to 0.3009 and 0.3020 were strong predictors of SS and focal sialadenitis, respectively, and constitute promising tools for SS clinical evaluation. It should be noted that the specificity and sensitivity of the Tfr cell: Tfh cell ratio to predict focal sialadenitis and SS were remarkably high, particularly given the small number of patients studied. We anticipate that greater patient numbers may reinforce the significance of our findings, potentially establishing the usefulness of Tfr and Tfh cell quantification for stratification of patients with primary SS. This is particularly important for both diagnostic and therapeutic purposes, as there are major unmet needs in these fields in primary SS (38) . The potential to confirm 782 FONSECA ET AL diagnosis in patients who do not fulfill classification criteria or to identify clusters of patients more prone to respond to targeted therapies are some of the applications that such a biomarker could have.
In the present study, we decided to study fresh blood of patients at the time of diagnosis and who were not receiving immunosuppressive agents to avoid potential drug effects on Tfh and Tfr cell subsets. Consequently, the studied cohort of patients was small but uniform and consistent. Other limitations of our study included the fact that paired samples for every parameter were in some cases not available, as well as the technical issue of CXCR5 staining in salivary gland cell suspension, which precluded a direct assessment of tissue Tfr cells at a phenotypic and functional level. It also remains to be shown whether alterations of Tfr and Tfh cell subsets that we describe here are specific for SS or can be generalized to other immune-mediated inflammatory diseases, particularly the ones with ectopic lymphoid structures and autoantibody-mediated pathology.
